Tenpoint Therapeutics Funding: $70M Raised, Series A (2023)
Tenpoint Therapeutics is based in London, UK. It has raised $70M in total funding. Latest round: Series A.
Tenpoint Therapeutics funding overview
Tenpoint Therapeutics is based in London, UK. Tenpoint Therapeutics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2023. The round record for Tenpoint Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include F-Prime Capital, Sofinnova Partners, British Patient Capital, Qiming Venture Partners USA, Eight Roads, UCL Technology Fund. 6 distinct backers are named across the disclosed rounds.
Tenpoint Therapeutics at a glance
Total raised
$70M
Latest round
Series A
Latest round date
July 2023
Headquarters
London, UK
Notable investors
F-Prime Capital, Sofinnova Partners, British Patient Capital, Qiming Venture Partners USA, Eight Roads, UCL Technology Fund
Frequently asked about Tenpoint Therapeutics funding
How much has Tenpoint Therapeutics raised?
Tenpoint Therapeutics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Tenpoint Therapeutics?
F-Prime Capital, Sofinnova Partners, British Patient Capital, Qiming Venture Partners USA, Eight Roads, UCL Technology Fund are named among the investors backing Tenpoint Therapeutics.
What was the latest Tenpoint Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2023.
Where is Tenpoint Therapeutics based?
Tenpoint Therapeutics is based in London, UK.
When did Tenpoint Therapeutics last raise?
The last disclosed Tenpoint Therapeutics round closed in July 2023 at Series A.
Round data for Tenpoint Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.
